<i>In vitro</i>and computational studies of the antioxidant and anti-diabetic properties of<i>Bridelia ferruginea</i>

Oyebode, Olajumoke A.; Erukainure, Ochuko L.; Zuma, Lindiwe; Ibeji, Collins U.; Koorbanally, Neil A.; Islam, Md. Shahidul

doi:10.1080/07391102.2020.1852961

Cited by 8 publications

(1 citation statement)

References 45 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Increased α-amylase and lipase activities have been implicated as a major contributor to hyperglycemia as it breaks down dietary carbohydrate and lipid to glucose and free fatty acids (FFAs), respectively, which causes a rise in postprandial blood glucose and FFAs levels [47,48]. The increased activities in serum and pancreas of the untreated diabetic rats (Figure 4a,b) therefore indicate a postprandial rise in blood glucose and FFAs levels, thus contributing to hyperglycemia.…”

Section: Discussionmentioning

confidence: 99%

Ferulic acid improves glucose homeostasis by modulation of key diabetogenic activities and restoration of pancreatic architecture in diabetic rats

Salau

Erukainure

Olofinsan

et al. 2022

Fundamemntal Clinical Pharma

Self Cite

View full text Add to dashboard Cite

There are increasing concerns on the rising cases of diabetes mellitus with type 2 diabetes (T2D) being of major interest as well as the cost of its treatment. Plant phenolic compounds are natural and potent antioxidants that have been widely reported for their antidiabetic activities properties, one of which is ferulic acid. The effect of ferulic acid (FA) on major diabetogenic activities and pancreatic architecture linked to T2D was investigated in T2D rats. T2D was induced in male Sprague–Dawley rats using the fructose‐streptozotocin model. Diabetic rats were treated with FA at 150 or 300 mg/kg bodyweight (bw). Normal control consisted of rats administered with food and water, while diabetic control consisted of untreated diabetic rats. Metformin was used as the standard drug. The rats were humanely sacrificed after 5 weeks of treatment. Their blood, liver, and pancreas were collected for analysis. Total glycogen content and carbohydrate metabolic enzymes activities were analyzed in the liver, while the pancreas and serum from blood were analyzed for oxidative stress biomarkers, purinergic and cholinergic enzyme activities, and amylase and lipase activities. The pancreatic tissue was further subjected to microscopic and histological examinations. FA caused a significant (p < 0.05) decrease in blood glucose level, with concomitant increase in serum insulin level. Treatment with FA also led to elevated levels of GSH, HDL‐c, SOD, and catalase activities, while concomitantly suppressing malondialdehyde, cholesterol, triglyceride, LDL‐c, NO, ALT, AST, creatinine, urea, and uric acid levels, acetylcholinesterase, ATPase, ENTPDase, 5′‐nucleotidase, lipase, glycogen phosphorylase, glucose‐6‐phosphatase, and fructose‐1,6‐biphosphatase activities. Histology analysis revealed an intact pancreatic morphology in FA‐treated diabetic rats. While transmission electron microscopy (TEM) analysis revealed an intact pancreatic ultrastructure and increased number of insulin granules in β‐cells. Taken together, these results portray that the antidiabetic potentials of ferulic acid involves modulation of major diabetogenic activities and maintenance of the pancreatic ultrastructure architecture.

show abstract

Section: Discussionmentioning

confidence: 99%